Diabetes insipidus

Overview

DI results from insufficient ADH (central) or renal insensitivity to ADH (nephrogenic), causing dilute polyuria. Distinguished from diabetes mellitus by normal blood glucose and absence of glycosuria.

Presentation

Polyuria - urine output >3 litres/24 hours
Polydipsia - intense thirst; preference for ice-cold water (distinguishing clue vs psychogenic polydipsia)
Nocturia and nocturnal enuresis in children
Hypernatraemia - when losses exceed intake; causes confusion, irritability, decreased consciousness

Investigations

🥇 First-line

serum osmolality (raised >295 mOsmol/kg in true DI), urine osmolality (inappropriately low <300 mOsmol/kg), blood glucose and urine dipstick (exclude diabetes mellitus), U&Es, calcium, potassium

🏆 Gold standard

water deprivation test with desmopressin challenge

🥈 Second-line

MRI pituitary and hypothalamus (structural cause in confirmed central DI)
Water deprivation test interpretation
ConditionSerum osmolalityUrine after deprivationUrine after desmopressin
Central DIHighLowRises (responds)
Nephrogenic DIHighLowStays low (no response)
Primary polydipsiaNormal or lowConcentrates normallyNormal

Differential diagnosis

Diabetes mellitus - raised blood glucose, glycosuria on dipstick, raised HbA1c; acanthosis nigricans suggests type 2 DM not DI
Primary polydipsia - serum osmolality normal or low; urine concentrates normally on water deprivation
SIADH - euvolaemic hyponatraemia with inappropriately concentrated urine; opposite biochemistry to DI
🎯
Acanthosis nigricans (hyperpigmentation and hyperkeratosis in axilla/groin) in a patient with polyuria, polydipsia, and hypertension points to type 2 diabetes mellitus - not DI.

Management

Central DI - first-line: desmopressin (synthetic ADH analogue; intranasal, sublingual, or oral) + treat underlying cause
Nephrogenic DI - first-line: remove/treat cause (stop lithium if safe, correct hypercalcaemia/hypokalaemia); low-sodium low-protein diet; thiazide diuretics (e.g. bendroflumethiazide) - paradoxically reduce urine volume via mild volume depletion increasing proximal tubular reabsorption
Nephrogenic DI - second-line: NSAIDs (e.g. indomethacin) - reduce prostaglandins, partially restoring collecting duct ADH sensitivity
Gestational DI: desmopressin - resistant to placental vasopressinase; resolves post-partum
⚠️
Desmopressin can cause dilutional hyponatraemia if fluid intake is not monitored, and must be used cautiously in ischaemic heart disease due to risk of vasoconstriction.

Types and causes

Central vs nephrogenic DI
FeatureCentral DINephrogenic DI
MechanismInsufficient ADH synthesis/releaseRenal insensitivity to ADH
Key acquired causesIdiopathic (25%), pituitary surgery, craniopharyngioma, sarcoidosis, haemochromatosis, head injuryLithium (most common drug cause, 10-15% of long-term users), hypercalcaemia, hypokalaemia, Sjögren's syndrome
Congenital causesAVP-NPII gene mutation (AD); Wolfram syndrome (DIDMOAD)X-linked V2 receptor mutation (90%); AQP2 mutation (10%)
ADH levelLowHigh (compensatory)
Response to desmopressinUrine osmolality risesUrine osmolality stays low
💡
Haemochromatosis causes central DI via iron deposition in hypothalamic neurons. Suspect when DI is accompanied by arthralgia, lethargy, raised ferritin, or family history of 'regular venesection'. It is autosomal recessive and can skip generations - confirm with serum ferritin.